Citius Pharmaceuticals, Inc. Proceeds from Issuance of Private Placement
Citius Pharmaceuticals, Inc. (CTXR) had Proceeds from Issuance of Private Placement of $125.00 thousand as of 2025-09-10, per its 10-K filed 2025-12-23.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-12-23
- Citius Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2021-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2021-06-30 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2017-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Citius Pharmaceuticals, Inc. proceeds from issuance of private placement for fiscal 2021 was $18.45M.
- Citius Pharmaceuticals, Inc. proceeds from issuance of private placement for fiscal 2017 was $556.15K, a 89.75% decline from fiscal 2016.
- Citius Pharmaceuticals, Inc. proceeds from issuance of private placement for fiscal 2016 was $5.43M, a 259.57% increase from fiscal 2015.
- Citius Pharmaceuticals, Inc. proceeds from issuance of private placement for fiscal 2015 was $1.51M, a 7.44% decline from fiscal 2014.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|
| 2025-09-10 | $125.00K 10-K · filed 2025-12-23 | ||||
| 2025-07-17 | $125.00K 10-K · filed 2025-12-23 | ||||
| 2023-06-30 | $771.00K 10-Q · filed 2023-08-14 | ||||
| 2023-05-08 | $13.80M 10-K · filed 2023-12-29 | ||||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $0.00 derived: sum of 2 quarters · filed 2022-12-22 | $18.45M 10-K · filed 2022-12-22 | ||
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $18.45M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $18.45M 10-Q · filed 2022-05-12 | ||||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $0.00 derived: sum of 2 quarters · filed 2019-12-16 | $308.95K derived: sum of 3 quarters · filed 2019-12-16 | $556.15K 10-K · filed 2019-12-16 | |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $308.95K derived: sum of 2 quarters · filed 2018-08-14 | $556.15K 10-Q · filed 2018-08-14 | $556.15K derived: sum of 4 quarters · filed 2018-12-11 | |
| 2017-03-31 | $308.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | $556.15K 10-Q · filed 2018-05-11 | $556.15K derived: sum of 3 quarters · filed 2018-12-11 | $1.59M derived: sum of 4 quarters · filed 2018-12-11 | |
| 2016-12-31 | $247.21K 10-Q · filed 2018-02-14 | $247.21K derived: sum of 2 quarters · filed 2018-12-11 | $1.28M derived: sum of 3 quarters · filed 2018-12-11 | $5.37M derived: sum of 4 quarters · filed 2018-12-11 | |
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $1.03M derived: sum of 2 quarters · filed 2018-12-11 | $5.13M derived: sum of 3 quarters · filed 2018-12-11 | $5.43M 10-K · filed 2018-12-11 | |
| 2016-06-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | $5.13M derived: sum of 2 quarters · filed 2017-08-14 | $5.43M 10-Q · filed 2017-08-14 | $5.86M derived: sum of 4 quarters · filed 2017-12-13 | |
| 2016-03-31 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | $4.40M 10-Q · filed 2017-05-15 | $4.83M derived: sum of 3 quarters · filed 2017-12-13 | $5.65M derived: sum of 4 quarters · filed 2017-12-13 | |
| 2015-12-31 | $302.44K 10-Q · filed 2017-02-14 | $732.88K derived: sum of 2 quarters · filed 2017-12-13 | $1.55M derived: sum of 3 quarters · filed 2017-12-13 | ||
| 2015-09-30 | $430.44K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-13 | $1.25M derived: sum of 2 quarters · filed 2017-12-13 | $1.51M 10-K · filed 2017-12-13 | ||
| 2015-06-30 | $819.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $1.08M 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | $260.00K 10-Q · filed 2016-05-20 | ||||
| 2014-09-30 | $1.63M 10-K · filed 2015-12-14 | $1.63M 10-K · filed 2016-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |